Satsuma Pharmaceuticals Inc (STSA) has fallen Monday morning, with the stock declining -4.72% in pre-market trading to 1.01. STSA's short-term technical score of 2 indicates that the stock has traded less bullishly over the last month than 98% of stocks on the market. In the Biotechnology industry, which ranks 88 out of 146 industries, STSA ranks higher than 2% of stocks. Satsuma Pharmaceuticals Inc has risen 1.92% over the past month, closing at $1.03 on April 24. During this period of time, the stock fell as low as $1.03 and as high as $1.09. STSA has an average analyst recommendation of Buy. The company has an average price target of $2.00.
News Home
Satsuma Pharmaceuticals Inc has a Long-Term Technical rank of 80. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 20% of the market scoring higher. In the Biotechnology industry which is number 86 by this metric, STSA ranks better than 86% of stocks.
Satsuma Pharmaceuticals Inc (STSA) Down 4.72% in Premarket Trading
Mentioned in this article
STSA has an Overall Score of 52. Find out what this means to you and get the rest of the rankings on STSA!